Abstract
Auto-inflammatory syndromes are a new group of distinct hereditable disorders characterized by episodes of seemingly unprovoked inflammation (most commonly in skin, joints, gut, and eye), the absence of a high titer of auto-antibodies or auto-reactive T cells, and an inborn error of innate immunity. A narrative literature review was carried out of studies related to auto-inflammatory syndromes to discuss the pathogenesis and clinical manifestation of these syndromes. This review showed that the main monogenic auto-inflammatory syndromes are familial Mediterranean fever (FMF), mevalonate kinase deficiency (MKD), Blau syndrome, TNF receptor-associated periodic syndrome (TRAPS), cryopyrin-associated periodic syndrome (CAPS), and pyogenic arthritis with pyoderma gangrenosum and acne (PAPA). The data suggest that correct diagnosis and treatment of monogenic auto-inflammatory diseases relies on the physicians' awareness. Therefore, understanding of the underlying pathogenic mechanisms of auto-inflammatory syndromes, and especially the fact that these disorders are mediated by IL-1 secretion stimulated by monocytes and macrophages, facilitated significant progress in patient management.
Keywords:
Auto-inflammatory syndrome; Fever; Inflammation; Innate immune response.
MeSH terms
-
Acne Vulgaris / drug therapy
-
Acne Vulgaris / genetics
-
Acne Vulgaris / immunology
-
Antirheumatic Agents / therapeutic use
-
Arthritis / drug therapy
-
Arthritis / genetics
-
Arthritis / immunology
-
Arthritis, Infectious / drug therapy
-
Arthritis, Infectious / genetics
-
Arthritis, Infectious / immunology
-
Cryopyrin-Associated Periodic Syndromes / drug therapy
-
Cryopyrin-Associated Periodic Syndromes / genetics
-
Cryopyrin-Associated Periodic Syndromes / immunology
-
Familial Mediterranean Fever / drug therapy
-
Familial Mediterranean Fever / genetics
-
Familial Mediterranean Fever / immunology
-
Hereditary Autoinflammatory Diseases / drug therapy
-
Hereditary Autoinflammatory Diseases / genetics
-
Hereditary Autoinflammatory Diseases / immunology*
-
Humans
-
Immunity, Innate / immunology
-
Infliximab / therapeutic use
-
Interleukin 1 Receptor Antagonist Protein / therapeutic use
-
Interleukin-1 / immunology*
-
Macrophages / immunology*
-
Mevalonate Kinase Deficiency / drug therapy
-
Mevalonate Kinase Deficiency / genetics
-
Mevalonate Kinase Deficiency / immunology
-
Monocytes / immunology*
-
Pyoderma Gangrenosum / drug therapy
-
Pyoderma Gangrenosum / genetics
-
Pyoderma Gangrenosum / immunology
-
Sarcoidosis
-
Synovitis / drug therapy
-
Synovitis / genetics
-
Synovitis / immunology
-
Uveitis / drug therapy
-
Uveitis / genetics
-
Uveitis / immunology
Substances
-
Antirheumatic Agents
-
Interleukin 1 Receptor Antagonist Protein
-
Interleukin-1
-
Infliximab
Supplementary concepts
-
Blau syndrome
-
Pyogenic arthritis, pyoderma gangrenosum, and acne